Faron Pharmaceuticals Oy (AIM:FARN)
London · Delayed Price · Currency is GBP · Price in GBX 39.60
-1.40 (-3.41%)
Aug 14, 2026, 4:35 PM GMT
Faron Pharmaceuticals Oy Market Cap
Faron Pharmaceuticals Oy has a market cap or net worth of 88.84 million as of August 14, 2026. Its market cap has decreased by -62.21% in one year.
Market Cap
88.84M
Enterprise Value
99.63M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
39.60
ChartMarket Cap Chart
Since November 17, 2015, Faron Pharmaceuticals Oy's market cap has increased from 53.46M to 88.84M, an increase of 66.18%. That is a compound annual growth rate of 4.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 88.84M | -56.86% |
| Dec 31, 2025 | 205.96M | -3.97% |
| Dec 31, 2024 | 214.48M | 2.23% |
| Dec 29, 2023 | 209.80M | 16.93% |
| Dec 30, 2022 | 179.42M | 26.00% |
| Dec 31, 2021 | 142.40M | 16.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Avacta Group | 299.78M |
| PureTech Health | 297.46M |
| Scancell Holdings | 116.37M |
| 4basebio | 81.58M |
| Bioventix | 78.37M |
| Ondine Biomedical | 71.44M |
| Poolbeg Pharma | 66.42M |
| hVIVO | 45.00M |